Skip to main content
. 2022 May 19;17(2):138–145. doi: 10.5114/pg.2022.116373

Table II.

Distribution of the pre-treatment endoscopic findings

Variable Group 1 n (%) Group 2 n (%) Group 3 n (%) Group 4 n (%) P-value
Endoscopic antral gastritis 47 (94) 49 (98) 49 (98) 49 (98) 0.56
Endoscopic erythematous pangastritis 12 (24) 14 (28) 13 (26) 14 (28) 0.96
Endoscopic erythematous bulbitis 19 (38) 11 (22) 11 (22) 11 (22) 0.17
Gastric ulcer 6 (12) 8 (16) 3 (6) 8 (16) 0.38
Bulbus ulcer 7 (14) 5 (10) 4 (8) 5 (10) 0.79